Hanson Kristopher

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 10. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 10
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
MapLight Therapeutics, Inc.General CounselOpen-market sell$192,66016,509 sharesSep 18, 2026MapLight Therapeutics, Inc.General Counsel$192,660Sell · Sep 18Open-market sell16,509Sep 18, 2026
MapLight Therapeutics, Inc.General CounselAwardnothing paid31,395 sharesAug 19, 2026MapLight Therapeutics, Inc.General Counselnothing paidAward · Aug 19Award31,395Aug 19, 2026
MapLight Therapeutics, Inc.General CounselAwardnothing paid7,730 sharesAug 19, 2026MapLight Therapeutics, Inc.General Counselnothing paidAward · Aug 19Award7,730Aug 19, 2026
MapLight Therapeutics, Inc.General CounselOpen-market sell$42,8271,130 sharesJul 17, 2026MapLight Therapeutics, Inc.General Counsel$42,827Sell · Jul 17Open-market sell1,130Jul 17, 2026
MapLight Therapeutics, Inc.General CounselOpen-market sell$41811 sharesJul 17, 2026MapLight Therapeutics, Inc.General Counsel$418Sell · Jul 17Open-market sell11Jul 17, 2026